Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses

被引:49
作者
Estcourt, MJ [1 ]
Létourneau, S [1 ]
McMichael, AJ [1 ]
Hanke, T [1 ]
机构
[1] John Radcliffe, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
关键词
rodent; T cells; vaccination; cytotoxic T cells; modified virus; Ankara; DNA; priming;
D O I
10.1002/eji.200535184
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The dynamics of primary CD8(+) T cell responses following administration of modified virus Ankara (MVA) - and DNA-vectored vaccines was investigated in a mouse model. To overcome the low frequency of naive antigen-specific precursors and follow the early expansion events, naive CFSE-labelled T cell receptor-transgenic F5 lymphocytes were transferred into syngeneic non-transgenic recipients prior to vaccination. Using the i.d., i.v. and i.m. routes and increasing recombinant WA (rMVA) vaccine doses, the primary response was analysed on a divisional basis at local and distant lymphoid organs at various times after vaccination. The results indicated that F5 cell divisions were initiated in the local draining lymph nodes and cells only after five to six divisions appeared at more distant sites. The rMVA dose affected frequencies of cells entering division and at the peak response. When priming induced by rMVA and plasmid DNA was compared, dramatic differences in the cycling patterns were observed with plasmid DNA inducing a response slower and more sustained over the first 2 wk than rMVA. Both rMVA and DNA induced comparable IFN-gamma production, which increased with cell divisions. Taken together, the vaccine type, dose and route have a strong influence on the spatial and temporal patterns of initial T cell responses.
引用
收藏
页码:2532 / 2540
页数:9
相关论文
共 68 条
[1]  
ALLAN W, 1990, J IMMUNOL, V144, P3980
[2]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[3]   Cutting edge: Rapid in vivo killing by memory CD8 T cells [J].
Barber, DL ;
Wherry, EJ ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :27-31
[4]   Estimating the precursor frequency of naive antigen-specific CD8 T cells [J].
Blattman, JN ;
Antia, R ;
Sourdive, DJD ;
Wang, XC ;
Kaech, SM ;
Murali-Krishna, K ;
Altman, JD ;
Ahmed, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :657-664
[5]   Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial [J].
Boyer, JD ;
Chattergoon, MA ;
Ugen, KE ;
Shah, A ;
Bennett, M ;
Cohen, A ;
Nyland, S ;
Lacy, KE ;
Bagarazzi, ML ;
Higgins, TJ ;
Baine, Y ;
Ciccarelli, RB ;
Ginsberg, RS ;
MacGregor, RR ;
Weiner, DB .
CLINICAL IMMUNOLOGY, 1999, 90 (01) :100-107
[6]   Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines [J].
Boyer, JD ;
Cohen, AD ;
Vogt, S ;
Schumann, K ;
Nath, B ;
Ahn, L ;
Lacy, K ;
Bagarazzi, ML ;
Higgins, TJ ;
Baine, Y ;
Ciccarelli, RB ;
Ginsberg, RS ;
MacGregor, RR ;
Weiner, DB .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :476-483
[7]   Massive expansion of antigen-specific CD8+ T cells during an acute virus infection [J].
Butz, EA ;
Bevan, MJ .
IMMUNITY, 1998, 8 (02) :167-175
[8]  
Cerwenka A, 1999, J IMMUNOL, V163, P5535
[9]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[10]   Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1 [J].
Coles, RM ;
Mueller, SN ;
Heath, WR ;
Carbone, FR ;
Brooks, AG .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :834-838